BAG5 regulates PTEN stability in MCF-7 cell line
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor-suppressing lipid phosphatase that is frequently absent in breast tumors. Thus, the stability of PTEN is essential for tumor prevention and therapy. The ubiquitinproteasome pathway has an important role in regulating the functions of PTEN. Specifically, carboxyl terminus Hsp70-interacting protein (CHIP), the E3 ubiquitin ligase of PTEN, can regulate PTEN levels. In this study, we report that BCL-2-associated athanogene 5 (BAG5), a known inhibitor of CHIP activity, reduces the degradation of PTEN and maintains its levels via an ubiquitylation-dependent pathway. BAG5 is identified as an antagonist of cell tumorigenicity. [BMB Reports 2013; 46(10): 490-494]
Abstract
The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor-suppressing lipid phosphatase that is frequently absent in breast tumors. Thus, the stability of PTEN is essential for tumor prevention and therapy. The ubiquitinproteasome pathway has an important role in regulating the functions of PTEN. Specifically, carboxyl terminus Hsp70-interacting protein (CHIP), the E3 ubiquitin ligase of PTEN, can regulate PTEN levels. In this study, we report that BCL-2-associated athanogene 5 (BAG5), a known inhibitor of CHIP activity, reduces the degradation of PTEN and maintains its levels via an ubiquitylation-dependent pathway. BAG5 is identified as an antagonist of cell tumorigenicity. [BMB Reports 2013; 46(10): 490-494]
참고문헌 (27)
- Li, J., "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer", Science, 275, pp.1943~1947 (1997)
- Steck, P. A., "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers", Nat. Genet, 15, pp.356~362 (1997)
- Carnero, A., "The PTEN", PI3K, Curr. Cancer Drug Targets, pp.2008, 8[DOI]
- Guldberg, P., "Disruption of the MMAC1", PTEN gene by deletion or mutation is a frequent event in malignant melanoma, 1997, pp.57, 3660~3663
- Wang, S. I., "Homozygous deletion of the PTEN tumour suppressor gene in a subset of prostate adenocarcinomas", Clin. Cancer Res, 4, pp.811~815 (1998)
- Rhei, E., "Mutation analysis of the putative tumour suppressor gene PTEN", MMAC1 in primary breast carcinomas, 1997, pp.57, 3657~3659
- Di Cristofano, A., "Pten is essential for embryonic development and tumour suppression", Nat. Genet, 19, pp.348~355 (1998)
- Trotman, L. C., "Pten dose dictates cancer progression in the prostate", PLoS Biol, 1, pp.385~396 (2003)
- Osaki, M., "PI3K-AKT pathway: its functions and alterations in human cancer", Apoptosis, 9, pp.667~676 (2004)
- Maddika, S., "Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy", Drug Resist Updat, 10, pp.13~29 (2007)
- Stambolic, V., "Negative regulation of PKB", AKT-dependent cell survival by the tumour suppressor PTEN, 1998, pp.95, 29~39
- Shen, W. H., "Essential role for nuclear PTEN in maintaining chromosomal integrity", Cell, 128, pp.157~170 (2007)
- Stambolic, V., "Regulation of PTEN transcription by p53", Mol. Cell, 8, pp.317~325 (2001)
- Wang, X., "Post-translational regulation of PTEN", Oncogene, 27, pp.5454~5463 (2008)
- Wang, X., "NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN", Cell, 128, pp.129~139 (2007)
- Maddika, S., "WWP2 is an E3 ubiquitin ligase for PTEN", Nat. Cell Biol, 13, pp.728~733 (2011)
- Ahmed, S. F., "The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation", J. Biol. Chem, 287, pp.15996~16006 (2012)
- Kalia, L. V., "Ubiquitinylation of a-Synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5)", Plos One, 6, pp.e14695~ (2011)
- Raftopoulou, M., "Regulation of cell migration by the C2 domain of the tumor suppressor PTEN", Science, 303, pp.1179~1181 (2004)
- Sansal, I., "The biology and clinical relevance of the PTEN tumor suppress or pathway", J. Clin. Oncol, 22, pp.2954~2963 (2004)
- Tamura, M., "Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN", Science, 280, pp.1614~1617 (1998)
- Liu, J., "Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13", Cell, 147, pp.223~234 (2011)
- Adey, N. B., "Threonine phosphorylation of the MMAC1", PTEN PDZ binding domain both inhibits and stimulates PDZ binding, 2000, pp.60, 35~37
- Leslie, N. R, "PTEN function: how normal cells control it and tumour cells lose it", Biochem. J, 382, pp.1~11 (2004)
- Torres, J., "The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation", J. Biol. Chem, 276, pp.993~998 (2001)
- Vazquez, F., "Phosphorylation of the PTEN tail regulates protein stability and function", Mol. Cell Biol, 20, pp.5010~5018 (2000)
- Yuan, J., "USP10 regulates p53 localization and stability by deubiquitinating p53", Cell, 140, pp.384~396 (2010)
